ALK+ Non-Small-Cell Lung Carcinoma

Also known as: ALK+ non small cell lung carcinoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB12130LorlatinibNot AvailableNot Yet Recruiting1